National Institute of General Medical Sciences; Notice of Closed Meeting, 88929-88930 [2023-28392]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices
comment received expressed support of
the proposed expansion.
Representatives from all seven MidAtlantic Tribes unanimously sought to
move forward collectively to request redesignation of their PRCDAs to include
the entire Commonwealth of Virginia.
Following consultation with those
Tribes, the IHS also considered portions
of Maryland and North Carolina that are
close to the border of Virginia. Since all
seven of the Mid-Atlantic Tribes
requested the same PRCDA, the IHS
considered these Tribes collectively for
purposes of the PRCDA expansion. This
included considering their Tribal
members collectively under the criteria
set forth in 42 CFR 136.22(b). In support
of this expansion, the IHS adopts the
following findings:
1. By expanding each Tribe’s PRCDA
and creating one collective PRCDA, the
seven Mid-Atlantic Tribes estimate the
current eligible population will
collectively increase by 1006
individuals.
2. The seven Mid-Atlantic Tribes have
determined that these 1006 individuals
are members of the federally recognized
Tribes in the Commonwealth of Virginia
and that these members are socially and
economically affiliated with these MidAtlantic Tribes.
3. Members of one or more of the
Tribes reside in each county that is
included in the proposed expansion,
and those members live near enough to
their Tribe’s seat of government to
maintain close social and economic ties
with their Tribe. According to the
leadership for each of the Tribes, those
members live close enough to regularly
participate—in-person—in Tribal
affairs, events, activities, or other
functions held by or carried out by the
Tribe within its current PRCDA.
Furthermore, the expanded PRCDA
counties and independent cities form a
contiguous area with the existing
PRCDAs. Considering the seven MidAtlantic Tribes collectively, the IHS has
determined the additional counties and
independent cities proposed for
inclusion herein to be geographically
proximate, meaning ‘‘on or near,’’ to the
area analogous to reservations for the
seven Mid-Atlantic Tribes.
4. PRC programs operated by/for the
seven Mid-Atlantic Tribes will use their
existing Federal allocation for PRC
funds to provide services to the
expanded population. No additional
financial resources will be allocated by
the IHS to these programs to provide
services to members residing in the
expanded counties and independent
cities in the Commonwealth of Virginia,
State of Maryland, or State of North
Carolina.
VerDate Sep<11>2014
20:25 Dec 22, 2023
Jkt 262001
An updated listing of the PRCDAs for
all federally recognized Tribes may be
accessed via a link under the
‘‘Purchased/Referred Care Delivery
Area’’ heading on the IHS PRC
Resources website (https://www.ihs.gov/
prc/resources).
Public Comments: The IHS received
one comment. The comment received
expressed support of the proposed
expansion.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2023–28313 Filed 12–22–23; 8:45 am]
BILLING CODE 4166–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Fellowships in
Digestive Diseases and Nutrition.
Date: February 15–16, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, Division of
Extramural Activities, NIDDK, National
Institutes of Health, Room 7111, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
88929
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28388 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Dominantly
Inherited Alzheimer Network.
Date: March 22, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Joshua Jin-Hyouk Park,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
7201 Wisconsin Avenue, Gateway Bldg. Suite
2W200, Bethesda, MD 20892, (301) 496–
6208, joshua.park4@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28390 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
E:\FR\FM\26DEN1.SGM
26DEN1
88930
Federal Register / Vol. 88, No. 246 / Tuesday, December 26, 2023 / Notices
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Centers of Biomedical
Research Excellence (COBRE) Phase III—
Transitional Centers (P30) Applications.
Date: March 12–13, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Manas Chattopadhyay,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN12N,
Bethesda, Maryland 20892, 301–827–5320,
manasc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28392 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
20:25 Dec 22, 2023
Jkt 262001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; MechanismBased Adult Stem Cell Treatments for Aging
Pathologies.
Date: January 19, 2024.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 7201
Wisconsin Avenue, Gateway Bldg. Suite
3208, Bethesda, MD 20892, 301–496–3562,
neuhuber@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28394 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Cancellation
of Meeting
Notice is hereby given of the
cancellation of the National Cancer
Institute Special Emphasis Panel, SEP–
11: NCI Clinical and Translational
Cancer Research, March 7, 2024, 10:00
a.m. to March 7, 2024, 1:30 p.m.,
National Cancer Institute Shady Grove,
Resources and Training Review Branch,
Division of Extramural Activities, 9609
Medical Center Drive, Room 7W238,
Rockville, Maryland, 20850 which was
published in the Federal Register on
December 20, 2023, FR Doc. 2023–
27963, 88 FR 88100.
This meeting is being cancelled and
will be rescheduled with a new contact
person.
Dated: December 20, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28371 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Clinical Trials and Translational
Research Advisory Committee.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting can be
accessed from the NIH VideoCast at the
following link: https://videocast.
nih.gov/.
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee.
Date: March 13, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: Strategic Discussion of NCI’s
Clinical and Translational Research
Programs.
Place: National Cancer Institute, 9609
Medical Center Drive, Rockville, MD 20850
(Virtual Meeting).
Contact Person: Sheila A. Prindiville, M.D.,
M.P.H., Director, Coordinating Center for
Clinical Trials, National Cancer Institute,
National Institutes of Health, 9609 Medical
Center Drive Room 6W136, Rockville, MD
20850 240–276–6173 prindivs@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ctac/ctac.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 19, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–28329 Filed 12–22–23; 8:45 am]
BILLING CODE 4140–01–P
Frm 00067
Fmt 4703
Sfmt 9990
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 88, Number 246 (Tuesday, December 26, 2023)]
[Notices]
[Pages 88929-88930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28392]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
[[Page 88930]]
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Review of Centers of Biomedical
Research Excellence (COBRE) Phase III--Transitional Centers (P30)
Applications.
Date: March 12-13, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute of
General Medical Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Manas Chattopadhyay, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN12N, Bethesda, Maryland 20892, 301-827-5320,
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.859,
Biomedical Research and Research Training, National Institutes of
Health, HHS)
Dated: December 20, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-28392 Filed 12-22-23; 8:45 am]
BILLING CODE 4140-01-P
